Cohance Lifesciences Limited (BOM:543064)
528.50
+0.80 (0.15%)
At close: Dec 31, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 200.27 billion as of December 31, 2025. Its market cap has decreased by -38.05% in one year.
Market Cap
200.27B
Enterprise Value
202.15B
Revenue
12.11B
Ranking
n/a
PE Ratio
113.16
Stock Price
528.50
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 200.27B, an increase of 594,096.40%. That is a compound annual growth rate of 345.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 200.27B | -0.96% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 21.25T |
| HDFC Bank | 15.25T |
| Bharti Airtel | 12.69T |
| Tata Consultancy Services | 11.68T |
| ICICI Bank | 9.60T |
| State Bank of India | 9.07T |
| Infosys | 6.54T |
| Bajaj Finance | 6.13T |